Roberto Chiarle

Company: ALKemist Bio

Job title: Scientific Founder

Seminars:

Spearheading Discovery & Validation of Novel Targets to Expand Indication & Treatment Potential 9:01 am

TCR-based therapies open a huge pool of intracellular target antigens that cannot be targeted by other therapeutics, but currently, success has only been seen in a small portion of this target repertoire. Therefore, it is imperative to diversify the range of effective targets, as well as to validate their tumor-specificity to mitigate against off-target effects…Read more

day: Workshop A